Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.
<iframe src="https://statesidedaily.com/embed/cluster/5b66a77a24e923af7bdc0d4d7c94691c4e3b355e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="The Trump administration's move to end subsidies for Medicare drug plans could cost consumers"></iframe>
Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.
